Akil H - Search Results

1

Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.

Lee KO, Akil H, Woods JH, Traynor JR. Lee KO, et al. Among authors: akil h. Eur J Pharmacol. 1999 Aug 13;378(3):323-30. doi: 10.1016/s0014-2999(99)00460-4. Eur J Pharmacol. 1999. PMID: 10493109

2

Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.

Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F. Emmerson PJ, et al. Among authors: akil h. J Pharmacol Exp Ther. 1996 Sep;278(3):1121-7. J Pharmacol Exp Ther. 1996. PMID: 8819494

3

Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.

Clark MJ, Emmerson PJ, Mansour A, Akil H, Woods JH, Portoghese PS, Remmers AE, Medzihradsky F. Clark MJ, et al. Among authors: akil h. J Pharmacol Exp Ther. 1997 Nov;283(2):501-10. J Pharmacol Exp Ther. 1997. PMID: 9353363

4

Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor.

Alt A, Mansour A, Akil H, Medzihradsky F, Traynor JR, Woods JH. Alt A, et al. Among authors: akil h. J Pharmacol Exp Ther. 1998 Jul;286(1):282-8. J Pharmacol Exp Ther. 1998. PMID: 9655870

5

Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor.

Remmers AE, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F. Remmers AE, et al. Among authors: akil h. J Pharmacol Exp Ther. 1999 Feb;288(2):827-33. J Pharmacol Exp Ther. 1999. PMID: 9918595

6

Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists.

Neilan CL, Akil H, Woods JH, Traynor JR. Neilan CL, et al. Among authors: akil h. Br J Pharmacol. 1999 Oct;128(3):556-62. doi: 10.1038/sj.bjp.0702816. Br J Pharmacol. 1999. PMID: 10516632 Free PMC article.

7

[3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain.

Young EA, Walker JM, Lewis ME, Houghten RA, Woods JH, Akil H. Young EA, et al. Among authors: akil h. Eur J Pharmacol. 1986 Mar 4;121(3):355-65. doi: 10.1016/0014-2999(86)90256-6. Eur J Pharmacol. 1986. PMID: 2870933 Free article.

8

Mapping the receptor domains critical for the binding selectivity of delta-opioid receptor ligands.

Meng F, Ueda Y, Hoversten MT, Thompson RC, Taylor L, Watson SJ, Akil H. Meng F, et al. Among authors: akil h. Eur J Pharmacol. 1996 Sep 12;311(2-3):285-92. doi: 10.1016/0014-2999(96)00431-1. Eur J Pharmacol. 1996. PMID: 8891611

9

Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop.

Bonner G, Meng F, Akil H. Bonner G, et al. Among authors: akil h. Eur J Pharmacol. 2000 Sep 1;403(1-2):37-44. doi: 10.1016/s0014-2999(00)00578-1. Eur J Pharmacol. 2000. PMID: 10969141

10

The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores.

Mansour A, Hoversten MT, Taylor LP, Watson SJ, Akil H. Mansour A, et al. Among authors: akil h. Brain Res. 1995 Nov 27;700(1-2):89-98. doi: 10.1016/0006-8993(95)00928-j. Brain Res. 1995. PMID: 8624732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

619 results

Search Page

Filters